New issuance started to wind down for the year in November, with eight mostly small IPOs raising a combined $348 million. Activity was well below the 10-year historical average (15 IPOs, $3.7B), though it's worth noting that deal flow often drops off in November...read more
Just one micro-cap and one SPAC listed this past week, after oil and gas producer Peak Resources (PRB) postponed its $66 million IPO at the eleventh-hour. Eight small IPOs and two SPAC submitted initial filings. Biomanufacturing company...read more
Invizyne Technologies, which is developing a biomanufacturing platform for a diverse range of chemicals, raised $15 million by offering 1.9 million shares at $8, as expected. Invizyne believes its biomanufacturing platform, SimplePath, will be a significant...read more
Invizyne Technologies, which is developing a biomanufacturing platform for a diverse range of chemicals, decreased its shares and increased the price range for its upcoming IPO on Friday. The Monrovia, CA-based company now plans to raise $15 million by offering...read more
Renaissance Capital's November IPO Market Update
New issuance started to wind down for the year in November, with eight mostly small IPOs raising a combined $348 million. Activity was well below the 10-year historical average (15 IPOs, $3.7B), though it's worth noting that deal flow often drops off in November...read more
US IPO Weekly Recap: 1 micro-cap lists and more enter pipeline, as Peak Resources postpones its IPO
Just one micro-cap and one SPAC listed this past week, after oil and gas producer Peak Resources (PRB) postponed its $66 million IPO at the eleventh-hour. Eight small IPOs and two SPAC submitted initial filings. Biomanufacturing company...read more
Biomanufacturing company Invizyne Technologies prices IPO at $8
Invizyne Technologies, which is developing a biomanufacturing platform for a diverse range of chemicals, raised $15 million by offering 1.9 million shares at $8, as expected. Invizyne believes its biomanufacturing platform, SimplePath, will be a significant...read more
Biomanufacturing company Invizyne Technologies revises terms ahead of $15 million IPO
Invizyne Technologies, which is developing a biomanufacturing platform for a diverse range of chemicals, decreased its shares and increased the price range for its upcoming IPO on Friday. The Monrovia, CA-based company now plans to raise $15 million by offering...read more